cannabis
In 2023, patients who switched from prescription opioids to medical cannabis cut their annual healthcare costs by up to 30%. This reduction reflects broader savings seen across medical, legal, and consumer spending when cannabis replaces traditional therapies. Medical Disclaimer: This article is for informational purposes only and does not constitute
cannabis
Yes, rescheduling cannabis from Schedule I to Schedule II can cut a corporation’s effective tax rate by about 12 percent, according to analysts. This change would let businesses treat many expenses as ordinary deductions, turning a costly tax regime into a cash-flow catalyst. For CFOs, the shift means more
cannabis
In 2025, True Harmony Company launched a state-of-the-art cannabis cultivation facility in Nevada, the first to integrate drone-guided irrigation. The technology standardizes water and nutrient delivery, cuts labor hours, and promises tighter chemical consistency, though it can also alter the plant's aromatic profile. Below is a side-by-side look
cannabis
In 1996, California’s Compassionate Use Act passed with 56% voter approval, according to Wikipedia, highlighting the public’s demand for trustworthy cannabis; the surest way to get authentic cold-pressed hemp oil is to verify low-temperature extraction, third-party lab results, and freshness cues. Cannabis Buyer’s Guide to Cold-Pressed Hemp
cannabis
35% Gains As Experts Publish Cannabis Benefits Vs Tax Federal rescheduling of cannabis to Schedule III can cut a midsize brand’s state tax burden by up to 35%, saving more than $1.5 million each year. Discover how the projected tax rescue could slash annual tax bills by over
cannabis
A leading fiscal analysis shows that an average mid-size cannabis company could reduce its tax bill by up to 15% - equivalent to $12 M in annual savings - if rescheduling succeeds. The change would stem from eliminating Internal Revenue Code Section 280E, which currently blocks ordinary deductions for cannabis
cannabis
A 2023 state health board audit found that seven Curaleaf health benefit claims lack solid peer-reviewed evidence. Marketers continue to promote those claims despite limited data, leaving consumers to sort hype from science. Medical Disclaimer: This article is for informational purposes only and does not constitute medical advice. Always consult
cannabis
Why Cannabis Benefits’s Killing Your Tax Strategy - Fix It In 2025, Deloitte reported that eliminating the 280E limitation can cut taxable income by up to 30 percent for mid-sized dispensaries. The lingering effects of outdated tax rules still drag many cannabis companies into higher liabilities, but recent rescheduling
cannabis
Cannabis Benefits vs Retinoid Creams Which Wins In 2026, Forbes highlighted a surge in CBD product popularity as consumers seek alternatives to traditional anti-aging creams. For post-menopausal women, hemp-derived topicals offer a natural route to smoother, more resilient skin without the irritation often linked to retinoids. "Consumers are increasingly
![Hemp Oil For Penis Enlargement: What The Evidence Actually Shows [IuXHmGlShbp] — Photo by SHVETS production on Pexels](https://images.pexels.com/photos/9775175/pexels-photo-9775175.jpeg?auto=compress&cs=tinysrgb&fit=crop&h=627&w=1200)
cannabis
Hemp oil does not increase penis size; clinical studies show no measurable growth after regular use. In 2026, a review of independent laboratory tests found zero participants with any size change after a 12-month hemp oil regimen. Advertisements that promise dramatic expansion ignore the lack of longitudinal data and the
cannabis
Financial Disclaimer: This article is for educational purposes only and does not constitute financial advice. Consult a licensed financial advisor before making investment decisions. Understanding Federal Excise Tax on Cannabis Industry insiders predict a 30% drop in federal excise taxes on cannabis, meaning startups could save tens of thousands of
cannabis
CFOs can leverage cannabis related tax strategies and rescheduling benefits to improve margins while preserving the core health and market advantages of the plant. In my work with emerging cannabis firms, I have seen finance leaders blend regulatory insight with operational agility to extract value from both the product and